Showing results for "#Bharat Biotech"
Bharat Biotech's intranasal booster dose may hit market in Feb
Earlier this month, Bharat Biotech received approval from the Central Drugs Standard Control Organization (CDSCO) for the use of heterologous booster...
Bharat Biotech completes phase-III trials for intranasal Covid vax
Bharat Biotech said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster...
Covid nasal vaccine's phase 3 trials completed: Bharat Biotech chief
India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal...
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Bharat Biotech has established Covaxin manufacturing to reach an annualised capacity of 1 billion doses by the end of 2021.
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
The DCGI to give emergency use authorisation to Corbevax COVID-19 vaccines for 5-12 age group soon, sources said.
SII to give free Covishield vials to pvt vaccination centres to...
Bharat Biotech had also announced that the price differential with any existing stocks of Covaxin in private hospitals shall be compensated in the...